Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wheatcroft, N. J.
Right arrow Articles by Weetman, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheatcroft, N. J.
Right arrow Articles by Weetman, A. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 12, 244-249, Copyright © 1997 by Oxford University Press

ARTICLES

Is subclinical ovarian failure an autoimmune disease?

NJ Wheatcroft, CA Rogers, RA Metcalfe, EA Lenton, ID Cooke and AP Weetman
Department of Medicine, University of Sheffield, UK.

Young women with unexplained infertility who exhibit elevated basal serum follicle stimulating hormone (FSH) concentrations (>10 IU/l) have poor outcomes in in-vitro fertilization. A subgroup of these women has regular menses, representing 'subclinical' ovarian failure, which may have an autoimmune basis and could potentially be treated by immunosuppression. To investigate this further, a range of immunological markers was used to assess autoimmune activity in 14 women aged <40 years with elevated FSH compared with 15 infertile women with normal FSH and 10 pre-menopausal, healthy controls. All samples were taken during natural menstrual cycles. Organ-specific antibodies against ovary, endometrium and thyroid, and non-organ-specific antibodies against histones and cardiolipin, were not significantly increased in elevated FSH patients compared with other control groups. Soluble CD23 and soluble intercellular adhesion molecule concentrations were not elevated in the sera of the women tested, and circulating T cell subsets remained unaltered. Significantly, increased concentrations of the complement breakdown product C3a and terminal complement complexes were detected in the elevated FSH group compared with the normal FSH group, although the latter also had significant complement activation compared with laboratory controls. Autoimmunity appears as an infrequent cause of 'subclinical' ovarian failure, but there is evidence of activation of complement in the sera of infertile women.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A. Sobek Jr, E. Tkadlec, B. Hladikova, and A. Sobek
Is there a declining trend in ovarian function among infertility clinic patients?
Hum. Reprod., October 28, 2009; (2009) dep372v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T. Forges, P. Monnier-Barbarino, G.C. Faure, and M.C. Bene
Autoimmunity and antigenic targets in ovarian pathology
Hum. Reprod. Update, March 1, 2004; 10(2): 163 - 175.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Luborsky, B. Llanes, R. Roussev, and C. Coulam
Ovarian antibodies, FSH and inhibin B: independent markers associated with unexplained infertility
Hum. Reprod., May 1, 2000; 15(5): 1046 - 1051.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
B. Ishizuka, Y. Kudo, A. Amemiya, H. Yamada, T. Matsuda, and T. Ogata
Anti-nuclear antibodies in patients with premature ovarian failure
Hum. Reprod., January 1, 1999; 14(1): 70 - 75.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.